Safety and Efficacy of RN9101 in the Treatment of Relapsed/Refractory Multiple Myeloma
NCT07628595
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
NOT_YET_RECRUITING
Status
19
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma (MM)
Interventions
DRUG:
RN9101 injection
Sponsor
The First Affiliated Hospital with Nanjing Medical University